Christopher P Rusconi

Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2

Siqing Shan, Mark W Dewhirst, M. Dewhirst, 2003, Proceedings of the National Academy of Sciences of the United States of America.

The potential of aptamers as anticoagulants.

B. Sullenger, R. Harrington, S. Nimjee, 2005, Trends in cardiovascular medicine.

Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer.

N Franklin Adkinson, Jeffrey Sailstad, Paul W Armstrong, 2016, The Journal of allergy and clinical immunology.

In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry

Fania Szlam, Kenichi A Tanaka, Kenichi A. Tanaka, 2009, Thrombosis and Haemostasis.

Aptamers: an emerging class of therapeutics.

B. Sullenger, S. Nimjee, C. Rusconi, 2005, Annual review of medicine.